By Nick Gilbert
Covalon Technologies, a medical technologies company, will exhibit its advanced medical coating abilities, including its FDA approved IV Clear, an antimicrobial silicone adhesive film dressing, and SilverCoat Antimicrobial Silicone Foley Catheter at the American Urological Association 2012 Annual Meeting ("AUA") in Atlanta, Georgia, from May 19 to May 23.
Brian Pedlar, CEO of Covalon, said that the company is hoping to present its SilverCoat Antimicrobial Silicone Foley Catheter along with its antimicrobial and lubricious coating at the AUA. He stated that the company has shown that its antimicrobial coating outperforms silver coated Foley catheters in destroying the bacteria commonly connected with urinary tract infections. Pedlar also said that the AUA has given Covalon the opportunity to exhibit its urological care products to the audience from all over the world.
The United States Center for Disease Control has identified that the most commonly affected healthcare-associated infections are urinary tract infections. Catheter associated urinary tract infections (CAUTIs) are the most common type of HAIs, accounting for 75% of infections.
The AUA Annual Meeting, which now celebrates its 107th year, is the largest meeting of urologists in the world and it provides access to new guidelines, groundbreaking research and the recent advances in urologic medicine.
Covalon will also be exhibiting its wound and antimicrobial silicone adhesive technology at the AUA. The company researches, develops and markets new medical devices that save lives throughout the world. Covalon’s technologies are utilized to detect, manage and prevent medical conditions in different areas such as infection control, tissue repair, wound care, disease management, biocompatibility and medical device coatings.